The Nuclear Medicine Clinical Trial Group, LLC (NMCTG) received its certificate of organization on August 24, 2005. Under the umbrella of the Society of Nuclear Medicine and Molecular Imaging, the NMCTG’s key purpose is to assist our partners and academic investigators with the execution and management of clinical research activities, including trial activities.
The goals of the NMCTG include ensuring quality imaging is conducted in drug or diagnostic clinical trials and providing training for molecular imaging professionals performing clinical research. Because the practice of clinical research is different from clinical practice, imaging personnel must be trained on how to meet requirements for image standardization and conformity within clinical research trials. To that end, many of the programs established under the Clinical Trials Network, including its robust Education Program, provide support to the NMCTG to help carry out is mission.